__________________________________________________________________________________________
30/JUN/2014
Re: Local ID TH131100086/ TH201311000604 FU (2)
Thank you for reporting to us an adverse event related to Lilly product.
We would like to collect more information to better understanding the reported event.
Please respond to following questions regarding the adverse event – face and legs edema, later reported as swelling, involving a patient who was subscribed Forteo, reported the event to Lilly on 01/NOV/2013.
Please try to obtain the following information with HCP (preferable) or from the patient:
1. Please clarify if the correct term of the events is edema or swelling.
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
2. In your opinion, are the events related to Forteo? Please include rationale of your assessment.
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
3. Please provide current status of the events and Forteo.
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
Thanks
Yours sincerely,
ELI LILLY AND COMPANY
Sasithorn Suntharo
Pharmacovigilance Associate
HCP’s signature:
Date:
__________________________________________________________________________________
For Eli Lilly internal use only
Date of Confirmation of FU request sent to HCP:
Name and Designation: